Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.
MacKenna B, Kennedy NA, Mehrkar A, Rowan A, Galloway J, Matthewman J, Mansfield KE, Bechman K, Yates M, Brown J, Schultze A, Norton S, Walker AJ, Morton CE, Harrison D, Bhaskaran K, Rentsch CT, Williamson E, Croker R, Bacon S, Hickman G, Ward T, Davy S, Green A, Fisher L, Hulme W, Bates C, Curtis HJ, Tazare J, Eggo RM, Evans D, Inglesby P, Cockburn J, McDonald HI, Tomlinson LA, Mathur R, Wong AYS, Forbes H, Parry J, Hester F, Harper S, Douglas IJ, Smeeth L, Lees CW, Evans SJW, Goldacre B, Smith CH, Langan SM. MacKenna B, et al. Among authors: norton s. Lancet Rheumatol. 2022 Jul;4(7):e490-e506. doi: 10.1016/S2665-9913(22)00098-4. Epub 2022 Jun 9. Lancet Rheumatol. 2022. PMID: 35698725 Free PMC article.
Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial.
Bechman K, Sin FE, Ibrahim F, Norton S, Matcham F, Scott DL, Cope A, Galloway J. Bechman K, et al. Among authors: norton s. RMD Open. 2018 May 17;4(1):e000676. doi: 10.1136/rmdopen-2018-000676. eCollection 2018. RMD Open. 2018. PMID: 29862047 Free PMC article.
Reply.
Matcham F, Hotopf M, Roberts E, Galloway J, Scott IC, Steer S, Norton S. Matcham F, et al. Among authors: norton s. Arthritis Rheumatol. 2019 Jun;71(6):1025-1026. doi: 10.1002/art.40843. Epub 2019 Apr 12. Arthritis Rheumatol. 2019. PMID: 30694024 No abstract available.
Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Bechman K, Clarke BD, Rutherford AI, Yates M, Nikiphorou E, Molokhia M, Norton S, Cope AP, Hyrich KL, Galloway JB. Bechman K, et al. Among authors: norton s. Rheumatology (Oxford). 2019 Oct 1;58(10):1767-1776. doi: 10.1093/rheumatology/kez037. Rheumatology (Oxford). 2019. PMID: 30982886
Placebo Response in Rheumatoid Arthritis Clinical Trials.
Bechman K, Yates M, Norton S, Cope AP, Galloway JB. Bechman K, et al. Among authors: norton s. J Rheumatol. 2020 Jan;47(1):28-34. doi: 10.3899/jrheum.190008. Epub 2019 May 1. J Rheumatol. 2020. PMID: 31043548 Free PMC article.
1,137 results